In This Article:
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where Nutex Health Inc. (NASDAQ:NUTX) stands against other healthcare stocks that are surging in 2025.
After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year. Healthcare spending has been continuously soaring and is projected to do so in the coming years due to demographic tailwinds. The industry now accounts for a fifth of the U.S. economy, and it’s a good idea to have exposure to it.
Most executives now hold a favorable view of the industry’s prospects, a notable increase from 52% just a year ago. Moreover, it’s an industry that is more insulated from tariffs and macro risks.
Of course, the top gainers here are not defensive healthcare stocks, but it’s still worth looking into the winners here if you are chasing potential multibaggers.
Even during bear markets, there are pockets of the market that perform exceptionally well. For example, I identified 15 Energy Stocks that are Up the Most in 2025 in another article.
Methodology
For this article, I screened the best-performing healthcare stocks year-to-date.
I will also mention the number of hedge fund investors in these stocks. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
A medical professional in scrubs providing care to a patient.
Nutex Health Inc. (NASDAQ:NUTX)
Number of Hedge Fund Holders In Q4 2024: 6
Nutex Health Inc. (NASDAQ:NUTX) is a physician-led healthcare services company operating micro-hospitals, population health management, and real estate segments across the United States.
The stock is up significantly so far in 2025 after the fourth-quarter and full-year 2024 earnings report, released in late March 2025, which showed total revenue nearly doubling to $479.9 million and net income swinging to $52.2 million from a $45.8 million loss the prior year. Adjusted EBITDA jumped over 1,000% to $123.7 million, and the hospital division saw visits rise by 17%.
A key driver behind this explosive growth was Nutex Health Inc. (NASDAQ:NUTX)’s strategic shift in mid-2024 to aggressively pursue arbitration under the No Surprises Act for out-of-network claims. This resulted in much higher reimbursement rates per visit and an over 80% success rate in claims.